Latest Articles

  • Tretinoin emollient cream 0.01% for the treatment of photoaged skin
    Judith M. Andreano, MD, Wilma F. Bergfeld, MD and Sharon Vanderbrug Medendorp, MPH
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 49-55;

    This low concentration appears safe and effective for retarding and reversing clinical changes associated with chronic exposure to UV light.

  • Physiologic evaluation of coronary flow: the role of positron emission tomography
    Loretta Isada, MD, Thomas H. Marwick, MD and William J. Macintyre, PhD
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 19-24;

    Quantitative documentation of the hemodynamic severity of coronary artery disease is more important than ever. A brief analysis of current imaging techniques.

  • PET in the evaluation of coronary artery disease
    Nlco H. J. Pijls, MD, PhD
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 86-87;
  • Multisystem autoimmune dysfunction with early onset of bullous emphysema
    Thomas M. Roy, MD, Cheryl L. Fields, MD and Karen R. Habenstein, MD
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 65-68;

    A 29-year-old man with alopecia universalis, autoimmune dysfunction, and rapidly progressing bullous emphysema.

  • Superior vena cava syndrome
    Alan W. Feld, MD
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 10;
  • Mechanical lithotripsy of large common bile duct stones
    Jacques Van Dam, MD, PhD and Michael V. Sivak, MD
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 38-42;

    This endoscopic technique is proving to be a safe, effective alternative to surgery.

  • Chemical and histological features of men with osteoporosis
    Angelo A. Licata, MD, PhD, Thomas W. Bauer, MD, PhD and Bernard Stulberg, MD
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 56-59;

    In this study group, increased parathyroid hormone secretion promoted a chronic high remodeling state which could have led to osteoporosis.

  • Forgoing life-supporting or death-prolonging therapy: a policy statement
    James P. Orlowski, MD, Robert L. Collins, MD and Susan N. Cancian, RN
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 81-85;

    The Cleveland Clinic Foundation’s policy offers general and specific guidelines for withdrawing life-sustaining therapy.

  • Dr. George W. Crile
    Floyd D. Loop, MD
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 75-80;
  • Commentary
    John J. Mulcahy, MD
    Cleveland Clinic Journal of Medicine January 1993, 60 (1) 74;

Pages